Glenn Ihde, MD

Quick Facts

  • Specialty: General Surgery
  • Primary Location: 600 Hospital Circle, Suite 201, Bay City, Texas, 77414
  • Direct: (979) 241-6100
  • Fax: (979) 241-6105
  • Insurance: Most major insurance plans, Medicare and Medicaid
  • Surgeon: Yes
  • Education: University of Kansas School of Medicine, Kansas City, Kansas
  • Graduated: 1993

Provider Profile

General surgeons are trained on anatomy, physiology, metabolism, immunology, nutrition, pathology, wound healing, shock and resuscitation, intensive care, and neoplasia, which are common to all surgical specialties. A general surgeon has specialized knowledge and experience related to the diagnosis, preoperative, operative, and postoperative management, including the management of complications, in nine primary components of surgery, all of which are essential to the education of a broadly-based surgeon. (Source: American College of Surgeons)

Dr. Ihde offers a full range of general surgery options here in Bay City, with common procedures including:

  • Upper Endoscopy/EGD
  • Lower Endoscopy/colonoscopies
  • Laparoscopic cholecystectomy and laparoscopic common bile duct exploration
  • Open and Laparoscopic inguinal hernia repair
  • Laparoscopic lysis of adhesions for small bowel obstruction
  • Laparoscopic colon resections for cancer or for diverticulitis
  • Breast cancer surgery and sentinel lymph node dissection
  • Laparoscopic hiatal hernia repair with transoral incisionless fundoplication (TIF) for reflux disease
  • Bariatric (weight loss) surgery

Special Recognition: Transoral Incisionless Fundoplication (TIF Procedure) for Reflux Disease

August 2020: Dr. Ihde has successfully treated over 700 reflux patients with the TIF® Procedure 

Bay City, Texas (August 2020) – Glenn Ihde, MD has treated more than 700 patients suffering from gastroesophageal reflux disease (GERD) with the TIF procedure.

TIF stands for Transoral Incisionless Fundoplication and has been used since 2007 to treat patients with both typical and atypical symptoms of GERD. Dr. Ihde started performing the TIF procedure in 2010, and his experience places him in the top 10% of all physicians trained to date.

Dr. Ihde said,“We’ve been using the TIF procedure to treat GERD patients because the procedure addresses the root cause of reflux and allows patients to control their symptoms without having to take medications for the rest of their lives. Patients avoid side effects associated with traditional surgery, and report similar outcomes to the published data, whereas most are off their daily PPI therapy and have improved quality of life survey scores.”

Schedule Your GERD/Reflux Consultation

If you are suffering from symptoms like heartburn, regurgitation, chronic cough and these symptoms are interfering with your ability to sleep or affecting your quality of life, contact Dr. Ihde at his office at Matagorda Medical Group located at 600 Hospital Circle, Suite 201, in Bay City, Texas or by phone at (979) 241-6100.

About Gastroesophageal Reflux Disease (GERD)

Gastroesophageal reflux disease (GERD) is a common gastrointestinal disease that affects nearly 20 percent of the U.S. population. It is a chronic condition in which the gastroesophageal valve (GEV) allows gastric contents to reflux (wash backwards) into the esophagus, causing heartburn and possible injury to the esophageal lining. In the United States (U.S.), GERD is the most common gastrointestinal-related diagnosis physicians make during clinical visits. Some patients may have mild or moderate symptoms of GERD, while others have more severe manifestations causing chronic heartburn, asthma, chronic cough, and hoarse voice or chest pain. The first treatment recommendation for patients with GERD is to make lifestyle changes (e.g., diet, scheduled eating times and sleeping positions). Proton pump inhibitor (PPI) medications are commonly used to treat GERD, but there are a variety of health complications associated with long-term dependency on PPIs, and more than 10 million Americans are refractory to PPI therapy and may opt for surgery.

About the TIF® Procedure with EsophyX® Device

The TIF 2.0 procedure enables an approach to fundoplication in which a device is inserted through the mouth, down the esophagus and into the upper portion of the stomach. This approach offers patients looking for an alternative to traditional surgery an effective treatment option to correct the underlying cause of GERD. Based on clinical studies, most patients stop using daily medications to control their symptoms and had their esophageal inflammation (esophagitis) eliminated up to five years after the TIF 2.0 procedure. Additionally, clinical results have demonstrated that concomitant laparoscopic hiatal hernia repair (LHHR) immediately followed by TIF 2.0 procedure is safe and effective in patients requiring repair of both anatomical defects.

The EsophyX technology is used to reconstruct the gastroesophageal valve (GEV) and restore its function as a barrier, preventing stomach acids from refluxing back into the esophagus. The device is inserted through the patient’s mouth with direct visual guidance from an endoscope, and enables creation of a 3 cm, 270° esophagogastric fundoplication. The U.S. Food and Drug Administration cleared the original EsophyX device in 2007. EndoGastric Solutions® launched the third generation EsophyX device, the EsophyX Z model, in 2015 and the EsophyX Z+ model, in 2017. The evolving EsophyX technology platform now enables surgeons and gastroenterologists to use a wide selection of endoscopes to treat the underlying anatomical cause of GERD. Over 25,000 TIF procedures have been performed worldwide. More than 100 peer-reviewed papers have consistently documented the sustained improved clinical outcomes and exemplary safety profile the TIF procedure provides to patients suffering from GERD.

About EndoGastric Solutions, Inc.

Based in Redmond, WA, EndoGastric Solutions, Inc. (, is a medical device company developing and commercializing innovative, evidence-based, surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop products and procedures to treat gastrointestinal diseases, including the TIF 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need. For more information, please visit

Join the conversation on Twitter: @GERDHelp, Facebook: @GERDHelp, and LinkedIn: EndoGastric Solutions